Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

'Shocking': Hospital inquiry urges axing of public-private partnership

A parliamentary committee has handed down its findings after an investigation into a Newcastle hospital where staff reported maggots falling from the ceiling.

'Shocking': Hospital inquiry urges axing of public-private partnership

A NSW parliamentary inquiry has called for the end of a Newcastle hospital's public-private partnership after uncovering shocking maintenance failures. The Calvary Mater Hospital, a leading cancer treatment facility in regional NSW, has faced a series of serious issues over the past year. These include a mould infestation, maggots on hospital floors, and a doctor fainting due to high humidity in operating theatres.

Greens MP Dr Amanda Cohn, who chaired the inquiry, described the revelations as "shocking" and said staff and whistleblowers reported numerous failures that could have been prevented. The report recommends the NSW government terminate the current public-private partnership and bring hospital management directly under NSW Health.

It also suggests re-evaluating the Orange and Bathurst Hospital partnerships. NSW Health Minister Ryan Park has not yet decided to return the hospital to public hands, but the government is reviewing the contract and addressing the challenges. The hospital's maintenance provider, Honeywell, is reviewing the report and committed to supporting the hospital and its staff.

The Health Services Union has urged the recommendations to be implemented urgently, calling for an end to the public-private partnership model in the health system.

Written by urgent.news from ABC News AU's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at abc.net.au →

More in Health & Medicine

Onshoring Is Here. The Hiring Wave Is Still a Decade Out

Building a highly technical, highly regulated pharmaceutical facility takes years, and we are in the part of the cycle where the work is physical, not scientific.

  • Pharmaceutical companies invested $370B in U.S. facilities since 2025.
  • Hiring surge for physical roles hasn't materialized yet.
  • Scientific workforce hiring expected within a decade.

More from Wednesday 5 August →